Key Points
-
TReg cells 'walk the line' by preventing autoimmunity while allowing the formation of protective antipathogen and antitumour immune responses.
-
TReg cells can be divided, based on their expression of activation and homing receptors, into populations with distinct migratory, functional and homeostatic characteristics.
-
TReg cells accumulate within both lymphoid and non-lymphoid tissues, and the proper localization of TReg cells is critical to their ability to function and maintain immune homeostasis in vivo.
-
TReg cells use distinct molecular programmes to restrain TH1, TH2 and TH17 cell-mediated immune responses.
-
TReg cells can alter their phenotype and function in response to molecular cues such as cytokines and vitamin metabolites that are present in the immune environment.
-
The phenotypical and functional stability of TReg cells remains controversial, and different experimental systems have yielded conflicting results regarding the ability of TReg cells to convert to other pro-inflammatory T cell lineages.
Abstract
Forkhead box P3 (FOXP3)+ regulatory T (TReg) cells prevent autoimmune disease, maintain immune homeostasis and modulate immune responses during infection. To accomplish these tasks, TReg cell activity is precisely controlled, and this requires TReg cells to alter their migratory, functional and homeostatic properties in response to specific cues in the immune environment. We review progress in understanding the diversity of TReg cells, TReg cell function in different anatomical and inflammatory settings, and the influence of the immune environment on TReg cell activity. We also consider how these factors affect immune-mediated disease in the contexts of infection, autoimmunity, cancer and transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
Horwitz, D. A. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res. Ther. 10, 227 (2008).
Viglietta, V., Baecher-Allan, C., Weiner, H. L. & Hafler, D. A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971–979 (2004).
Ehrenstein, M. R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200, 277–285 (2004).
Lindley, S. et al. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 54, 92–99 (2005).
Belkaid, Y. Regulatory T cells and infection: a dangerous necessity. Nature Rev. Immunol. 7, 875–888 (2007).
Nishikawa, H. & Sakaguchi, S. Regulatory T cells in tumor immunity. Int. J. Cancer 127, 759–767 (2010).
Feuerer, M., Hill, J. A., Mathis, D. & Benoist, C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nature Immunol. 10, 689–695 (2009).
Campbell, D. J., Kim, C. H. & Butcher, E. C. Chemokines in the systemic organization of immunity. Immunol. Rev. 195, 58–71 (2003).
Sather, B. D. et al. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335–1347 (2007).
Dudda, J. C., Perdue, N., Bachtanian, E. & Campbell, D. J. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559–1565 (2008).
Suffia, I., Reckling, S. K., Salay, G. & Belkaid, Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174, 5444–5455 (2005).
Freyschmidt, E. J. et al. Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses. J. Immunol. 185, 1295–1302 (2010).
Schneider, M. A., Meingassner, J. G., Lipp, M., Moore, H. D. & Rot, A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 204, 735–745 (2007).
Yamazaki, T. et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181, 8391–8401 (2008).
Santodomingo-Garzon, T., Han, J., Le, T., Yang, Y. & Swain, M. G. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49, 1267–1276 (2008).
Muller, M. et al. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 179, 2774–2786 (2007).
Zhang, N. et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. 30, 458–469 (2009). This study showed that T Reg cells must accumulate in both the draining lymph node and transplanted tissue in order to prevent islet allograft rejection.
Lee, J. H., Kang, S. G. & Kim, C. H. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178, 301–311 (2007).
Huehn, J. et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303–313 (2004). This study was the first to demonstrate that, based on their expression of homing receptors, T Reg cells could be subdivided into populations resembling naive T cells and effector- or memory-like T cells.
Min, B. et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur. J. Immunol. 37, 1916–1923 (2007).
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. & Sacks, D. L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507 (2002). This study demonstrated that T Reg cells at the site of infection can impair pathogen clearance and thereby help to maintain a depot of antigen that contributes to persistence of pathogen-specific immunity.
Loser, K. et al. IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol. 179, 365–371 (2007).
Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 28, 546–558 (2008). This paper defined the essential contribution of T Reg cell-derived IL-10 in preventing inflammatory disease at barrier tissues.
Wing, K. et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271–275 (2008). This study demonstrated that T Reg cells must express CTLA4 to prevent fatal lymphoproliferative autoimmune disease.
Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206–1212 (2003).
Onodera, T. et al. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J. Immunol. 183, 5608–5614 (2009).
Tadokoro, C. E. et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203, 505–511 (2006).
Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83–92 (2006). References 29 and 30 used two-photon microscopy to demonstrate that within lymph nodes T Reg cells interact predominantly with DCs.
Boissonnas, A. et al. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity. 32, 266–278 (2010).
Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 8, 191–197 (2007).
Lund, J. M., Hsing, L., Pham, T. T. & Rudensky, A. Y. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320, 1220–1224 (2008).
Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nature Rev. Immunol. 8, 523–532 (2008).
Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445–489 (2010).
Chen, Z., Laurence, A. & O'Shea, J. J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19, 400–408 (2007).
Szabo, S. J., Sullivan, B. M., Peng, S. L. & Glimcher, L. H. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21, 713–758 (2003).
Ansel, K. M., Djuretic, I., Tanasa, B. & Rao, A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24, 607–656 (2006).
Ivanov, I. I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).
Zheng, W. & Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587–596 (1997).
Dardalhon, V., Korn, T., Kuchroo, V. K. & Anderson, A. C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 31, 252–256 (2008).
Kim, H. Y., DeKruyff, R. H. & Umetsu, D. T. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nature Immunol. 11, 577–584 (2010).
Townsend, M. J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity. 20, 477–494 (2004).
Szabo, S. J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002).
Sullivan, B. M., Juedes, A., Szabo, S. J., von Herrath, M. & Glimcher, L. H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl Acad. Sci. USA 100, 15818–15823 (2003).
Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunol. 10, 595–602 (2009).
Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351–356 (2009).
Kwon, H. et al. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity. 31, 941–952 (2009).
Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986–991 (2009). Along with references 47 and 48, this study demonstrated that T Reg cells utilize distinct molecular programmes to control T H 1-, T H 2- and T H 17-type responses.
Liu, G. et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nature Immunol. 10, 769–777 (2009). This study showed that, through selective induction of the AKT–mTOR pathway, S1P 1 restrains thymic T Reg generation and peripheral T Reg function.
Strober, W. Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol. 1, 92–95 (2008).
Ghoreishi, M. et al. Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol. J. Immunol. 182, 6071–6078 (2009).
Jeffery, L. E. et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183, 5458–5467 (2009).
Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453–479 (2008).
Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003).
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunol. 6, 1142–1151 (2005).
Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723–735 (2005). This paper showed that IL-2 produced by effector or memory CD4+ T cells controls T Reg cell homeostasis.
Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R. & Farrar, M. A. IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280–290 (2007).
Soper, D. M., Kasprowicz, D. J. & Ziegler, S. F. IL-2Rβ links IL-2R signaling with Foxp3 expression. Eur. J. Immunol. 37, 1817–1826 (2007).
Burkett, P. R. et al. Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200, 825–834 (2004).
Siewert, C. et al. Induction of organ-selective CD4+ regulatory T cell homing. Eur. J. Immunol. 37, 978–989 (2007).
Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256–260 (2007).
Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764 (2007).
Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775–1785 (2007).
Zhou, X. et al. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J. Immunol. 185, 2675–2679 (2010).
Gorman, S. et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179, 6273–6283 (2007).
Sigmundsdottir, H. et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nature Immunol. 8, 285–293 (2007).
Murphy, K. M. et al. T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. Curr. Top. Microbiol. Immunol. 238, 13–26 (1999).
Cooper, A. M. et al. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178, 2243–2247 (1993).
Harty, J. T. & Bevan, M. J. Specific immunity to Listeria monocytogenes in the absence of IFNγ. Immunity. 3, 109–117 (1995).
Wang, Z. E., Reiner, S. L., Zheng, S., Dalton, D. K. & Locksley, R. M. CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179, 1367–1371 (1994).
Caretto, D., Katzman, S. D., Villarino, A. V., Gallo, E. & Abbas, A. K. Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J. Immunol. 184, 30–34 (2010).
Lu, L. F. et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914–929 (2010). This study demonstrated that the microRNA miR-146a dampens STAT1 activity in T Reg cells and prevents them from acquiring pro-inflammatory effector functions.
Oldenhove, G. et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity. 31, 772–786 (2009). This paper showed that during intestinal infection with Toxoplasma gondii , T Reg cells downregulate FOXP3, acquire T H 1 effector functions and contribute to infection-associated immunopathology.
Kishimoto, T. IL-6: from its discovery to clinical applications. Int. Immunol. 22, 347–352 (2010).
Bettelli, E., Oukka, M. & Kuchroo, V. K. TH-17 cells in the circle of immunity and autoimmunity. Nature Immunol. 8, 345–350 (2007).
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006). This study defined the role of IL-6 in controlling T H 17 and iT Reg cell differentiation.
Zheng, S. G., Wang, J. & Horwitz, D. A. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112–7116 (2008).
Xu, L., Kitani, A., Fuss, I. & Strober, W. Cutting edge: regulatory T cells induce CD4+CD25−Foxp3− T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 178, 6725–6729 (2007).
Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
Mima, T. & Nishimoto, N. Clinical value of blocking IL-6 receptor. Curr. Opin. Rheumatol. 21, 224–230 (2009).
Dardalhon, V. et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells. Nature Immunol. 9, 1347–1355 (2008).
Veldhoen, M. et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature Immunol. 9, 1341–1346 (2008).
Pillemer, B. B. et al. STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells. J. Immunol. 183, 155–163 (2009).
Maerten, P. et al. Effects of interleukin 4 on CD25+CD4+ regulatory T cell function. J. Autoimmun. 25, 112–120 (2005).
Trinchieri, G. Type I interferon: friend or foe? J. Exp. Med. 207, 2053–2063 (2010).
Namdar, A., Nikbin, B., Ghabaee, M., Bayati, A. & Izad, M. Effect of IFN-β therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study. J. Neuroimmunol. 218, 120–124 (2010).
Vandenbark, A. A. et al. Interferon-β-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. J. Neuroimmunol. 215, 125–128 (2009).
Golding, A., Rosen, A., Petri, M., Akhter, E. & Andrade, F. Interferon-α regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology 131, 107–117 (2010).
Hoffman, H. M. Therapy of autoinflammatory syndromes. J. Allergy Clin. Immunol. 124, 1129–1138 (2009).
Chen, X. & Oppenheim, J. J. TNF-α: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr. Dir. Autoimmun. 11, 119–134 (2010).
Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. & Oppenheim, J. J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179, 154–161 (2007).
Ma, H. L. et al. Tumor necrosis factor α blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum. 62, 430–440 (2010).
Brinster, C. & Shevach, E. M. Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3− T cells. J. Leukoc. Biol. 84, 480–487 (2008).
Deknuydt, F., Bioley, G., Valmori, D. & Ayyoub, M. IL-1β and IL-2 convert human Treg into TH17 cells. Clin. Immunol. 131, 298–307 (2009).
Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS. Biol. 5, e38 (2007).
Tsuji, M. et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323, 1488–1492 (2009).
Komatsu, N. et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl Acad. Sci. USA 106, 1903–1908 (2009).
Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007).
Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunol. 10, 1000–1007 (2009).
Wei, G. et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 30, 155–167 (2009). By performing genome-wide analysis of histone modification, this study demonstrated the potential for substantial functional plasticity in CD4+ T cell subsets.
Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010). Along with reference 101, this study used lineage tracing to examine the phenotypical and functional stability of T Reg cells in different immune settings.
Akbar, A. N., Vukmanovic-Stejic, M., Taams, L. S. & Macallan, D. C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nature Rev. Immunol. 7, 231–237 (2007).
Allan, S. E. et al. CD4+ T-regulatory cells: toward therapy for human diseases. Immunol. Rev. 223, 391–421 (2008).
Picca, C. C. et al. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol. Rev. 212, 74–85 (2006).
Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J. & Hsieh, C. S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205, 3105–3117 (2008).
Tang, Q. et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348–3352 (2003).
Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12, 431–440 (2000).
Darrasse-Jeze, G. et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206, 1853–1862 (2009). This paper demonstrated that, in vivo , T Reg cell and DC homeostasis are intricately linked.
Bollyky, P. L. et al. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 86, 567–572 (2009).
Venturi, G. M., Conway, R. M., Steeber, D. A. & Tedder, T. F. CD25+CD4+ regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover. J. Immunol. 178, 291–300 (2007).
Szanya, V., Ermann, J., Taylor, C., Holness, C. & Fathman, C. G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461–2465 (2002).
Hirahara, K. et al. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J. Immunol. 177, 4488–4494 (2006).
Siegmund, K. et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097–3104 (2005).
Denning, T. L., Kim, G. & Kronenberg, M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174, 7487–7491 (2005).
Lim, H. W., Lee, J., Hillsamer, P. & Kim, C. H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180, 122–129 (2008).
Yuan, Q. et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204, 1327–1334 (2007).
Kang, S. G. et al. Identification of a chemokine network that recruits FoxP3+ regulatory T cells into chronically inflamed intestine. Gastroenterology 132, 966–981 (2007).
Yurchenko, E. et al. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203, 2451–2460 (2006).
Kleinewietfeld, M. et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T cell subset. Blood 105, 2877–2886 (2004).
Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803–2812 (2007).
Soler, D. et al. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J. Immunol. 177, 6940–6951 (2006).
Guo, Z. et al. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int. Immunol. 20, 307–315 (2008).
Eksteen, B. et al. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 177, 593–603 (2006).
Oo, Y. H. et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J. Immunol. 184, 2886–2898 (2010).
Lim, H. W., Broxmeyer, H. E. & Kim, C. H. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J. Immunol. 177, 840–851 (2006).
Lim, H. W., Hillsamer, P. & Kim, C. H. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J. Clin. Invest. 114, 1640–1649 (2004).
Grauer, O. M. et al. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int. J. Cancer 121, 95–105 (2007).
Wald, O. et al. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma. J. Immunol. 177, 6983–6990 (2006).
Acknowledgements
The authors would like to thank all past and present members of the Campbell lab for interesting discussions and intellectual input essential to this Review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Campbell, D., Koch, M. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11, 119–130 (2011). https://doi.org/10.1038/nri2916
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri2916
This article is cited by
-
How chemokines organize the tumour microenvironment
Nature Reviews Cancer (2024)
-
Protection of lipopolysaccharide-induced otic injury by a single dose administration of a novel dexamethasone formulation
Translational Medicine Communications (2023)
-
Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity
Nature Immunology (2023)
-
Gut Treg cells release IL-27 to regulate TH17 cell responses
Nature Immunology (2023)
-
Regulatory T cells in autoimmune kidney diseases and transplantation
Nature Reviews Nephrology (2023)